Market closed
Assertio/$ASRT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Assertio
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
Ticker
$ASRT
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
58
Website
Assertio Metrics
BasicAdvanced
$60M
-
-$0.23
0.81
-
Price and volume
Market cap
$60M
Beta
0.81
52-week high
$1.80
52-week low
$0.62
Average daily volume
415K
Financial strength
Current ratio
1.766
Quick ratio
1.344
Long term debt to equity
32.055
Total debt to equity
35.421
Interest coverage (TTM)
-6.81%
Management effectiveness
Return on assets (TTM)
-3.11%
Return on equity (TTM)
-16.66%
Valuation
Price to revenue (TTM)
0.478
Price to book
0.49
Price to tangible book (TTM)
1.48
Price to free cash flow (TTM)
2.263
Growth
Revenue change (TTM)
-17.83%
Earnings per share change (TTM)
-95.08%
3-year revenue growth (CAGR)
4.02%
3-year earnings per share growth (CAGR)
97.18%
What the Analysts think about Assertio
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Assertio stock.
Assertio Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Assertio Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Assertio News
AllArticlesVideos
Assertio to Participate in the iAccess Alpha Virtual Best Ideas Conference on March 25-26, 2025
GlobeNewsWire·2 weeks ago
Assertio Holdings, Inc. (ASRT) Q4 2024 Earnings Call Transcript
Seeking Alpha·4 weeks ago
Assertio Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewsWire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Assertio stock?
Assertio (ASRT) has a market cap of $60M as of April 06, 2025.
What is the P/E ratio for Assertio stock?
The price to earnings (P/E) ratio for Assertio (ASRT) stock is 0 as of April 06, 2025.
Does Assertio stock pay dividends?
No, Assertio (ASRT) stock does not pay dividends to its shareholders as of April 06, 2025.
When is the next Assertio dividend payment date?
Assertio (ASRT) stock does not pay dividends to its shareholders.
What is the beta indicator for Assertio?
Assertio (ASRT) has a beta rating of 0.81. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.